A multicenter randomized controlled trial of a liquid loperamide product versus placebo in the treatment of acute diarrhea in children

Clicks: 453
ID: 115278
1999
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 10 articles by views in Clinical pediatrics

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
This randomized, double-blind, placebo-controlled trial of 48 hours' duration conducted in 13 primary care ambulatory practices in the United States and Mexico was used to compare the efficacy and safety of loperamide with placebo for the treatment of acute diarrhea in children aged 2 through 11 yea …
Reference Key
ma1999clinicala Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kaplan MA;Prior MJ;McKonly KI;DuPont HL;Temple AR;Nelson EB;;
Journal Clinical pediatrics
Year 1999
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10544864
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male Child Infant preschool Clinical Trial Randomized Controlled Trial Double-Blind Method Multicenter Study placebos acute disease diarrhea loperamide / therapeutic use* pmid:10544864 doi:10.1177/000992289903801003 m a kaplan m j prior e b nelson infantile / drug therapy* loperamide / pharmacology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.